Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
Under what circumstances would you consider treating with steroid therapy in a patient with HIV-associated nephropathy?
Related Questions
Do you recommend initiating immunosuppression and plasmapheresis in patients with dialysis dependent AKI in the setting of anti-GBM disease who do not have pulmonary involvement?
How would you approach managing an asymptomatic patient with normal kidney function who has elevated p-ANCA and MPO titers along with evidence for pauci-immune glomerulonephritis on kidney biopsy?
What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?
How do various therapeutic approaches for IgA nephropathy target the different stages of the four-hit hypothesis?
Which clinical characteristics would prompt you to consider an oral factor B inhibitor such as iptacopan in the treatment of IgA nephropathy?
How would you treat idiopathic isolated renal TMA diagnosed on renal biopsy without evidence of MAHA?
What factors do you consider when advising a patient with lupus nephritis on the safety of becoming pregnant?
How do you approach distinguishing between primary and secondary FSGS in a patient who is PLA2R negative?
Do you use delayed-release budesonide over prednisone or methylprednisolone for the treatment of IgA nephropathy, considering the available safety and efficacy data?
How often do you check fibrinogen levels and when do you administer FFP for patients with AKI requiring plasma exchange?
